Toxicodendron Poisoning

Back

Practice Essentials

Toxicodendron dermatitis is an allergic contact dermatitis (allergic phytodermatitis) that occurs from exposure to urushiol, a skin-irritating oil produced by members of the plant genus Toxicodendron. In North America, this includes poison ivy, poison oak, and, much less frequently, poison sumac. Although technically not Toxicodendron species, mangoes and Japanese lacquer trees also contain urushiol and can incite a similar clinical picture. A large number of other botanicals that produce a similar reaction mediated by different irritant chemicals also exist. See the image below.



View Image

Forearm approximately 10 days after exposure to poison ivy in a garden. Note vesicles and linear areas of the rash.

See 11 Common Plants That Can Cause Dangerous Poisonings, a Critical Images slideshow, to help identify plant reactions and poisonings.

Treatment of toxicodendron dermatitis comprises the following (see Treatment):

Pathophysiology

Toxicodendron species contain oleoresins known collectively as urushiol. In susceptible individuals, these compounds can trigger a type IV delayed hypersensitivity reaction. Usually, the skin is involved; however, the eyes, airway, and lungs may be involved if exposed to smoke from burning plants. Reactions from gastrointestinal exposure in the form of urushiol-containing homeopathic remedies have also been reported.[1]

In susceptible individuals, lesions generally appear within 12-48 hours, although they have been noted to appear earlier. New lesions may continue to appear for up to 2-3 weeks. Initially, these lesions tend to occur from the slow reaction to adsorbed urushiol; however, lesions that appear later are often secondary to contact with contaminated surfaces (eg, clothing, pet hair, gardening tools, camping equipment). Although a common misconception, fluid from the vesicles of a poison ivy rash does not contain urushiol and is not an irritant source for new lesions.

Epidemiology

Frequency

United States

Toxicodendron species are abundant throughout the United States except in desert areas, elevations above 4000 ft, Alaska, and Hawaii. Poison oak is most common west of the Rockies, poison ivy to the east, and poison sumac in the southeast.

Approximately 50-70% of the United States population is susceptible if exposed casually; however, this percentage increases with significant exposure. Approximately 10-15% of the population is extremely sensitive. Toxicodendron dermatitis is the most common cause of contact dermatitis in the United States, exceeding all other causes combined. According to the 2016 Annual Report of the American Association of Poison Control Centers' National Poison Data System, skin irritation from Toxicodendron was the third most common plant exposure, accounting for 1594 cases.[2]

International

Toxicodendron dermatitis occurs outside North America. However, the most prevalent form of plant dermatitis worldwide occurs from exposure to the numerous members of the family Compositae and varied sesquiterpene lactone allergens from these plants. With increasing global travel and transport of plants, true toxicodendron dermatitis is being increasingly reported in Europe, although it is still case reportable.[3, 4]

Mortality/Morbidity

Morbidity is related to sensitivity of the individual exposed as well as the degree and route of exposure. Morbidity ranges from localized mild erythema and pruritus to diffuse erythema, edema, severe pain, and pruritus with bullous lesions. Secondary infection can complicate the dermatitis.

Race-, Sex-, and Age-related Demographics

No clear racial difference in susceptibility exists. No difference in susceptibility between the sexes exists. Elderly people have reduced sensitivity.

History

The history in cases of possible Toxicodendron toxicity should include questions about the following:

Physical

The dermatitis is highly variable and depends on the sensitivity of the patient and extent of exposure.

Mild cases

In mild cases, classic lesions on exposed skin are secondary to brushing against the plant or excoriations from scratching. Characteristics of mild classic lesions are as follows:

Moderate-to-severe cases

Characteristics of moderate-to-severe cases are as follows:

Uncommonly, dermatitis from exposure to poison ivy may include black spots. The spots consist of urushiol oleoresins, which harden within minutes of exposure to air to form a black resin.[5, 6]

Erythema multiforme is an atypical presentation of toxicodendron dermatitis reported after sumac ingestion.

Causes

Dermatitis from urushiol oleoresins follows exposure to members of the plant genus Toxicodendron.

Poison ivy (Toxicodendron rydbergii), poison oak (Toxicodendron diversilobum), and poison sumac (Toxicodendron vernix) are most common in North America.[7]

Urushiol can also be found in mango plants and the Japanese lacquer tree (Rhus verniciflua), although these are not Toxicodendron species; mango fruit skin can cause reactions in susceptible individuals.[8]

Exposure to unroasted cashew nut shells can cause a dermatitis often confused with toxicodendron dermatitis in susceptible individuals. Roasting inactivates the allergen.

Approach Considerations

Toxicodendron dermatitis is a clinical diagnosis. Laboratory testing is usually not necessary as part of the emergency department evaluation.

Patch testing is discouraged for toxicodendron dermatitis because it might sensitize an unsensitized individual. However, if contact dermatitis is being considered, patch testing for other allergens might be considered.

Leaf spray mass spectrometry, which is a new ambient ionization method, can detect allergenic urushiols directly from poison ivy with no sample preparation; the results show all the urushiols reported using liquid chromatography mass spectrometry methods. The identifications were confirmed with tandem mass spectrometry analysis of the leaf spray ions. Enhanced detection of some urushiols was achieved in the negative mode if chloride anions were added to the spray solvent.[9] This technique, although not yet readily available, has been used to confirm the diagnosis of black-spot poison ivy, which may clinically resemble melanoma.[5]

Prehospital Care

Preventive measures for toxicodendron dermatitis includes using barriers. Classic preventive strategies include wearing long sleeves, long pants, and gloves. Vinyl gloves are preferred because they will not absorb the urushiol as readily as leather or fabric gloves. Rubber gloves can be permeable to urushiol.

A number of commercially available creams are marketed to prevent penetration of urushiol into the skin. The published data on these remedies are limited and conflicting. Although some protective effect is suggested, the degree of protection and the cost-to-benefit ratio are unclear.

The initial treatment of toxicodendron dermatitis is to wash the affected area as soon as possible after exposure. Washing exposed areas with copious amounts of water within 20 minutes of exposure has been shown to reduce reactivity.[10] The efficacy of washing appears to decrease over time.

Emergency Department Care

Treatment can be considered in the following three categories:

Decontamination

Immediate decontamination: Urushiol penetrates the skin and binds to membrane lipids within 10-20 minutes of contact. If the toxin can be removed before this occurs, reaction can be avoided.

Although multiple products are marketed for skin decontamination, they are only slightly more efficacious than soap and water.[11] Copious water is recommended because soaps can spread the urushiol oil around the skin.

It is important to instruct patients to clean their clothes and any other objects that might have been in contact with the oils.

Topical or symptomatic care

Topical preparations for symptomatic relief are the standard care for poison ivy exposure. Calamine (a combination of zinc oxide and ferric oxide), oatmeal baths, and Burow solution (an aqueous solution of aluminium triacetate, Domeboro®), all have been recommended. To prevent ground oatmeal from caking in pipes, it can be placed in a tied sock before being dropped in the bathtub.

Zanfel®, a soap mixture of ethoxylate and sodium lauroyl sarcosinate surfactants, is a product that is claimed to bind the urushiol resin for a number of days after exposure. It has been aggressively marketed. Limited data on this product show a mild benefit of up to 6 days after experimental exposure.[12]

A number of herbally based folk remedies (eg, jewelweed[13] ) have been proposed over the years and are receiving some new attention, although none can be particularly endorsed at this time.[14] A study by Abrams Motz and colleagues confirmed that jewelweed mash is effective for preventing development of dermatitis after poison ivy contact, but is less effective than soap.[15] These researchers subsequently confirmed that saponins in jewelweed are responsible for this effect.[16]

Oral antihistamines can be of some benefit for the relief of pruritus, especially in severe cases with urticarial lesions accompanying the bullae.

Low-potency topical steroids and topical antihistamines have not been shown to have any beneficial effect.

Oral analgesics (eg, acetaminophen, nonsteroidal anti-inflammatory drugs [NSAIDs]) occasionally are required for very severe cases, especially as an aid to sleep.

Immunomodulation

Systemic steroids are the standard treatment for severe toxicodendron dermatitis. These generally are given orally, although some authors prefer high-potency steroid creams (fluocinonide or clobetasol propionate applied topically twice a day for a week and then once a day for a week) if started early in the course.

Orally, various bursts of prednisone or methylprednisolone are used. These medications should be tapered off for at least 10-14 days (up to 3 wks). A study by Curtis and Lewis in 49 patients with severe poison ivy dermatitis found that patients who received a 5-day burst followed by a 10-day taper were significantly less likely to utilize other medications, compared with patients who received a burst regimen only (22.7% vs. 55.6%, P = 0.02). The longer regimen consisted of 5 days of 40 mg oral prednisone daily followed by the following taper[17] :

Early withdrawal of steroid therapy can lead to a recrudescence of the lesions. Therefore, avoid premade dose packs, and emphasize to the patient the importance of finishing his or her course of medication.

Medication Summary

The goals of pharmacotherapy are to reduce morbidity and to prevent complications. Oral antihistamines can be of some benefit for the relief of pruritus. Systemic steroids are the standard for severe toxicodendron dermatitis.

Prednisone (Deltasone)

Clinical Context:  Immunosuppressant that may decrease inflammation by reversing increased capillary permeability and suppressing PMN activity. DOC used in moderate-to-severe cases. Blocks type IV hypersensitivity reaction.

Methylprednisolone (Solu-Medrol)

Clinical Context:  Steroids ameliorate delayed effects of anaphylactoid reactions and may limit biphasic anaphylaxis. In severe cases of serum sickness, parenteral steroids may be beneficial to reduce inflammatory effects of this immune complex–mediated disease. Available as PO/IV preparations.

Class Summary

These agents have anti-inflammatory properties and cause profound and varied metabolic effects. They modify the body's immune response to diverse stimuli.

Diphenhydramine (Benadryl)

Clinical Context:  For symptomatic relief of symptoms caused by release of histamine in allergic reactions.

Hydroxyzine (Vistaril, Atarax)

Clinical Context:  Antagonizes H1 receptors in periphery. May suppress histamine activity in subcortical region of CNS. Sedating, alternative to diphenhydramine.

Cimetidine (Tagamet)

Clinical Context:  If no response to H1 antagonist alone, coadministration with this H2 antagonist treats itching and flushing in anaphylaxis, pruritus, urticaria, and contact dermatitis.

Class Summary

These agents provide symptomatic relief of pruritus.

Further Outpatient Care

Patients should follow up with their primary care physician.

All contaminated clothing and articles should be washed. Pets that have been exposed should be bathed well to remove the oil from their fur.

Precautions include watching for secondary bacterial infection of skin lesions.

Deterrence/Prevention

Avoid exposure. Protective clothing, such as gloves (nonlatex), should be worn if handling the plants or contaminated objects or animals.

A number of barrier creams and lotions are available. Although they cannot completely eliminate the reaction, they can diminish the exposure.

Complications

Potential complications include the following:

Prognosis

Complete resolution is expected within 7-21 days.

Patient Education

Instruct the patient that the fluid from the bullae is not an irritant and cannot extend the rash.

If steroids have been given, caution the patient on the risks of rebound flare if steroid therapy is stopped prematurely.

For patient education information, see the Allergies Center, as well as Poison Ivy, Oak, and Sumac.

Author

Steven L Stephanides, MD, Attending Physician, Department of Emergency Medicine, Eisenhower Medical Center

Disclosure: Nothing to disclose.

Coauthor(s)

Chris Moore, MD, PhD, Medical Director, Department of Emergency Medicine, Virginia Mason Medical Center

Disclosure: Nothing to disclose.

Specialty Editors

John T VanDeVoort, PharmD, Regional Director of Pharmacy, Sacred Heart and St Joseph's Hospitals

Disclosure: Nothing to disclose.

Chief Editor

Michael A Miller, MD, Clinical Professor of Emergency Medicine, Medical Toxicologist, Department of Emergency Medicine, Texas A&M Health Sciences Center; CHRISTUS Spohn Emergency Medicine Residency Program

Disclosure: Nothing to disclose.

Additional Contributors

Miguel C Fernandez, MD, FAAEM, FACEP, FACMT, FACCT, Associate Clinical Professor, Department of Surgery/Emergency Medicine and Toxicology, University of Texas School of Medicine at San Antonio; Medical and Managing Director, South Texas Poison Center

Disclosure: Nothing to disclose.

Acknowledgements

Michael Hodgman, MD Assistant Clinical Professor of Medicine, Department of Emergency Medicine, Bassett Healthcare

Michael Hodgman, MD is a member of the following medical societies: American College of Medical Toxicology, American College of Physicians, Medical Society of the State of New York, and Wilderness Medical Society

Disclosure: Nothing to disclose.

References

  1. Cardinali C, Francalanci S, Giomi B, et al. Contact dermatitis from Rhus toxicodendron in a homeopathic remedy. J Am Acad Dermatol. 2004 Jan. 50(1):150-1. [View Abstract]
  2. Gummin DD, Mowry JB, Spyker DA, Brooks DE, Fraser MO, Banner W. 2016 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 34th Annual Report. Clin Toxicol (Phila). 2017 Dec. 55 (10):1072-1252. [View Abstract]
  3. Leclercq RM. [Severe contact-allergy dermatitis due to poison ivy--a plant that is rarely encountered in The Netherlands; a family history]. Ned Tijdschr Geneeskd. 2005 Jul 23. 149(30):1697-700. [View Abstract]
  4. Gach JE, Tucker W, Hill VA. Three cases of severe Rhus dermatitis in an English primary school. J Eur Acad Dermatol Venereol. 2006 Feb. 20(2):212-3. [View Abstract]
  5. Rader RK, Mu R, Shi H, Stoecker WV, Hinton KA. Dermoscopy of black-spot poison ivy. Dermatol Online J. 2012 Oct 15. 18(10):8. [View Abstract]
  6. Chastant LR, Davis T, Libow L. Black-spot poison ivy, a report of 3 cases with clinicopathologic correlation. JAAD Case Rep. 2018 Mar. 4 (2):140-142. [View Abstract]
  7. Botanical dermatology: allergic contact dermatitis. Electronic Textbook of Dermatology. Available at http://telemedicine.org/botanica/bot6.htm. Accessed: July 5, 2018.
  8. Thoo CH, Freeman S. Hypersensitivity reaction to the ingestion of mango flesh. Australas J Dermatol. 2008 May. 49(2):116-9. [View Abstract]
  9. Tadjimukhamedov FK, Huang G, Ouyang Z, Cooks RG. Rapid detection of urushiol allergens of Toxicodendron genus using leaf spray mass spectrometry. Analyst. 2012 Mar 7. 137(5):1082-4. [View Abstract]
  10. Neill BC, Neill JA, Brauker J, Rajpara A, Aires DJ. Post-exposure prevention of toxicodendron dermatitis with early forceful unidirectional washing. J Am Acad Dermatol. 2018 Feb 1. [View Abstract]
  11. Stibich AS, Yagan M, Sharma V, Herndon B, Montgomery C. Cost-effective post-exposure prevention of poison ivy dermatitis. Int J Dermatol. 2000 Jul. 39(7):515-8. [View Abstract]
  12. Davila A, Laurora M, Fulton J, Jacoby J, Reed J, Heller M. A new topical agent, Zanfel, ameliorates urushiol-induced Toxicodendron allergic contact dermatitis. Ann Emerg Med. 2003. 42(4 supp 1):Abstract no 364; s98.
  13. Abrams Motz V, Bowers CP, Mull Young L, Kinder DH. The effectiveness of jewelweed, Impatiens capensis, the related cultivar I. balsamina and the component, lawsone in preventing post poison ivy exposure contact dermatitis. J Ethnopharmacol. 2012 Aug 30. 143(1):314-8. [View Abstract]
  14. Canavan D, Yarnell E. Successful treatment of poison oak dermatitis treated with Grindelia spp. (Gumweed). J Altern Complement Med. Aug 2005. 11(4):709-11. [View Abstract]
  15. Abrams Motz V, Bowers CP, Mull Young L, Kinder DH. The effectiveness of jewelweed, Impatiens capensis, the related cultivar I. balsamina and the component, lawsone in preventing post poison ivy exposure contact dermatitis. J Ethnopharmacol. 2012 Aug 30. 143 (1):314-8. [View Abstract]
  16. Motz VA, Bowers CP, Kneubehl AR, Lendrum EC, Young LM, Kinder DH. Efficacy of the saponin component of Impatiens capensis Meerb.in preventing urushiol-induced contact dermatitis. J Ethnopharmacol. 2015 Mar 13. 162:163-7. [View Abstract]
  17. Curtis G, Lewis AC. Treatment of severe poison ivy: a randomized, controlled trial of long versus short course oral prednisone. J Clin Med Res. 2014 Dec. 6 (6):429-34. [View Abstract]
  18. [Guideline] Contact dermatitis: a practice parameter. Ann Allergy Asthma Immunol. 2006 Sep. 97(3 Suppl 2):S1-38. [View Abstract]
  19. Shofner JD, Kimball AB. Plant-induced dermatitis. Auerbach PS, Ed. Wilderness Medicine. 6th ed. Philadelphia PA: Elsevier Mosby; 2012. 1232-50.
  20. Oh SH, Haw CR, Lee MH. Clinical and immunologic features of systemic contact dermatitis from ingestion of Rhus (Toxicodendron). Contact Dermatitis. 2003 May. 48(5):251-4. [View Abstract]

Forearm approximately 10 days after exposure to poison ivy in a garden. Note vesicles and linear areas of the rash.

Forearm approximately 10 days after exposure to poison ivy in a garden. Note vesicles and linear areas of the rash.